The cytomegalovirus-“safe” blood product: Is leukoreduction equivalent to antibody screening?
- 30 April 2000
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 14 (2) , 112-136
- https://doi.org/10.1016/s0887-7963(00)80003-6
Abstract
No abstract availableThis publication has 133 references indexed in Scilit:
- Posttransfusion graft-versus-host disease in infancyThe Journal of Pediatrics, 1990
- Posttransfusion cytomegalovirus infection in neonates: Role of saline-washed red blood cellsThe Journal of Pediatrics, 1986
- Acquisition of Donor Strains of Cytomegalovirus by Renal-Transplant RecipientsNew England Journal of Medicine, 1986
- Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow TransplantationNew England Journal of Medicine, 1986
- Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysisThe Journal of Pediatrics, 1985
- Occupational Risk for Primary Cytomegalovirus Infection among Pediatric Health-Care WorkersNew England Journal of Medicine, 1983
- Sequelae of maternally derived cytomegalovirus infections in premature infantsThe Journal of Pediatrics, 1983
- Prevention of transfusion-acquired cytomegalovirus infections in newborn infantsThe Journal of Pediatrics, 1981
- Cytomegaloviruria in older infants in intensive care nurseriesThe Journal of Pediatrics, 1979
- Cytomegaloviremia in children with acute lymphocytic leukemiaThe Journal of Pediatrics, 1975